Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials
- PMID: 32011927
- DOI: 10.1161/CIRCULATIONAHA.120.045008
Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials
Keywords: Editorials; cardiomyopathy; heart failure; neprilysin; renin-angiotensin system; sex; valsartan; ventricular function.
Comment on
-
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.Circulation. 2020 Feb 4;141(5):338-351. doi: 10.1161/CIRCULATIONAHA.119.044491. Epub 2019 Nov 17. Circulation. 2020. PMID: 31736337
-
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.Circulation. 2020 Feb 4;141(5):352-361. doi: 10.1161/CIRCULATIONAHA.119.044586. Epub 2019 Nov 17. Circulation. 2020. PMID: 31736342
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical